Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin- dependent kinase inhibitor genes in human parathyroid adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3663-3667

  Tahara, Hideki ^a   Smith, Alison P ^a   Gaz, Randall D ^a   Arnold, Andrew ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; GENE PRODUCT;

ARTICLE; CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 9P; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; DNA SEQUENCE; GENE DELETION; GENE LOCUS; HUMAN; HUMAN TISSUE; PARATHYROID ADENOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; ENZYME INHIBITORS; GENE DELETION; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PARATHYROID NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN KINASE INHIBITORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0029836726     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3663     Document Type: Article

References (39)

1. Arnold A, Kim HG, Gaz RD, et al. 1989 Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest. 83:2034-2040.
2. Motokura T, Bloom T, Kim HG, et al. 1991 A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 350:512-515.
3. Rosenberg CL, Kim HG, Shows TB. Kronenberg HM, Arnold A. 1991 Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid adenomas. Oncogene. 6:449-453.
4. Friedman E, Sakaguchi K, Bale AE, et al. 1989 Clonality of parathyroid tumors in familial multiple endocrine neoplasia type I. N Engl J Med. 321:213-218.
5. Arnold A, Kim HG. 1989 Clonal loss of one chromosome 11 in a parathyroid adenoma. J Clin Endocrinol Metab. 69:496-499.
6. Bystrom C, Larsson C, Blomberg C, et al. 1990 Localization of the MEN1 gene to a small region within 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA. 87:1968-1972.
7. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A. 1995 Frequent loss of chromosome arm Ip DNA in parathyroid adenomas. Genes Chrom Cancer. 13:9-17.
8. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. 1996 Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res. 56:599-605.
9. Arnold A. 1995 The Cyclin D1/PRAD1 oncogene in human neoplasia. J Invest Med. 43:543-549.
10. Sherr CJ. 1994 G1 phase progression: cycling on cue. Cell. 79:551-555.
11. Hunter T, and Pines J. 1994 Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:573-582.
12. Serrano M, Hannon GJ, Beach D. 1993 A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:704-707.
13. INK4B is a potential effector of cell cycle arrest mediated by TGF-β. Nature. 371:257-261.
14. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. 1994 Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368:753-756.
15. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. 1994 A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:436-440.
16. Jen J, Harper JW, Bigner SH, et al. 1994 Deletion of p16 and p15 genes in brain tumors. Cancer Res. 54:6353-6358.
17. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y. 1994. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54:3396-3397.
18. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA. 1995 p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet. 4:1569-1577.
19. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular cloning-a laboratory manual, 2nd ed. Cold Spring Harbor Cold Spring Harbor Laboratory; 9.16-9.19.
20. Litt M, Hauge X, Sharma V. 1993 Shadow bands seen when typing polymorphic dinucleotide repeats: some causes and cures. BioTechniques. 15:280-284.
21. Ueki K, Rubio M-P, Ramesh V, et al. 1994 MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet. 3:1841-1845.
22. Habets GGM, van der Kammem RA, Willemsen V, Balemans M, Wiegant J, Collard JG. 1992 Sublocalization of an invasion-inducing locus and other genes on human chromosome 7. Cytogenet Cell Genet. 60:200-4205.
23. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. 1993 The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics. 16:325-332.
24. Merlo A, Herman JG, Mao L, et al. 1995 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers. Nature Med. 1:686-692.
25. Herman JG, Merlo A, Mao L, et al. 1995 Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530.
26. Caldas C, Hahn SA, da Costa LT, et al. 1994 Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8:27-32.
27. INK4 function. Nature Genet. 10:114-116.
28. Cairns P, Mao Li, Merlo A, et al. 1994 Rate of p16 (MTS1) mutations in primary tumors with 9p loss. Science. 265:415-416.
29. Spruck III CH, Gonzalez-Zulueta M, Shibata A, et al. 1994 p16 gene in uncultured tumours. Nature. 370:183-184.
30. Zhou X, Tarmin L, Yin J, et al. 1994 The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene. 9:3737-3741.
31. Nakagawa K, Conrad NK, Williams JP, Johnson BE, Kelly MJ. 1995 Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Oncogene. 11:1843-1851.
32. Hussussian CJ, Struewing JP, Goldstein AM, et al. 1994 Germline p16 mutations in familial melanoma. Nature Genet. 8:15-21.
33. Gruis NA, van der Velden PA, Sandkuijl LA, et al. 1995 Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet. 10:351-353.
34. INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene. 11:405-412.
35. Hsi ED, Zukerberg LR, Yang WI, Arnold A. 1996 Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab. 81:1736-1739.
36. Waga S, Hannon GJ, Beach D, Stillman B. 1994 The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:574-578.
37. Li R, Waga S, Hannon GJ, Beach, Stillman B. 1994 Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature. 371:534-537.
38. Kwiatkowski DJ, Armour J, Bale AE, et al. 1993 Report on the Second International Workshop on Human Chromosome 9. Cytogenet Cell Genet. 64:94-103.
39. Gyapay G, Morissette J, Vignal A, et al. 1994 The 1993-94 Genethon human genetic linkage map. Nature Genet. 7:246-339.